Price Reversal Pattern of ARV Drugs: A Transaction-Cost Approach Digression
Frank Lorne and
Additional contact information
Frank Lorne: New York Institute of Technology-Vancouver
Sneh Shah: New York Institute of Technology-Vancouver
Expert Journal of Economics, 2015, vol. 3, issue 2, 93-112
A price reversal pattern of ARV drugs was noted across lower and middle income countries in that the lower-income countries have higher prices relative to higher-income countries based on a 2008-2009 Summary Report by World Health Organization. The transaction costs affecting AVR drug pricing can be broadly classified into two kinds: One between the final users and the opinion/knowledge experts, and the other between the opinion/knowledge experts and the manufacturers. Economist’s version of price discrimination needs to be modified by including transaction costs. Transaction costs also point to institution creditability factors that will affect NGO procurement.
Keywords: transaction costs; price discrimination; patents; price differentials; health NGOs (search for similar items in EconPapers)
JEL-codes: D3 D4 (search for similar items in EconPapers)
References: View references in EconPapers View complete reference list from CitEc
Citations Track citations by RSS feed
Downloads: (external link)
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:exp:econcs:v:3:y:2015:i:2:p:93-112
Access Statistics for this article
More articles in Expert Journal of Economics from Sprint Investify
Series data maintained by Alin Opreana ().